Phase III Win In Kidney Disease For Ardelyx's Tenapanor

 
• By Kevin Grogan
  
Burden
Tenapanor could reduce high pill burden for hyperphosphatemia patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Genitourinary

More from Therapeutic Category